Oncologie
Hematopoëtische stamceltransplantatie zonder bloedtransfusie
Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (opent nieuw venster)
Bron: Br J Haematol 2013;161(5):738-40.
Geïndexeerd: PubMed 23480574
DOI: 10.1111/bjh.12284
https://www.ncbi.nlm.nih.gov/pubmed/23480574 (opent nieuw venster)
Autologous stem-cell transplantation can be performed safely without the use of blood-product support. (opent nieuw venster)
Bron: J Clin Oncol 2004;22(20):4087-94.
Geïndexeerd: PubMed 15353543
DOI: 10.1200/JCO.2004.01.144
https://www.ncbi.nlm.nih.gov/pubmed/15353543 (opent nieuw venster)
Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients. (opent nieuw venster)
Bron: Bone Marrow Transplant 2020;55(6):1059-67.
Geïndexeerd: PubMed 31898692
DOI: 10.1038/s41409-019-0777-9
https://www.ncbi.nlm.nih.gov/pubmed/31898692 (opent nieuw venster)
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products. (opent nieuw venster)
Bron: Bone Marrow Transplant 2006;37(3):325-7.
Geïndexeerd: PubMed 16314850
DOI: 10.1038/sj.bmt.1705223
https://www.ncbi.nlm.nih.gov/pubmed/16314850 (opent nieuw venster)
Hematopoietic stem cell transplantation without the use of blood components by the patient's choice: experience of 2 Brazilian centers. (opent nieuw venster)
Bron: Biol Blood Marrow Transplant 2020;26(3):458-62.
Geïndexeerd: PubMed 31669397
DOI: 10.1016/j.bbmt.2019.10.018
https://www.ncbi.nlm.nih.gov/pubmed/31669397 (opent nieuw venster)
Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - literature review and local experience. (opent nieuw venster)
Bron: Transfus Apher Sci 2017;56(3):317-21.
Geïndexeerd: PubMed 28642120
DOI: 10.1016/j.transci.2017.05.022
https://www.ncbi.nlm.nih.gov/pubmed/28642120 (opent nieuw venster)
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (opent nieuw venster)
Bron: J Clin Oncol 2015;33(15):1674-9.
Geïndexeerd: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
https://www.ncbi.nlm.nih.gov/pubmed/25870085 (opent nieuw venster)
Myeloablative chemotherapy and autologous stem cell transplantation without the use of blood products. (opent nieuw venster)
Bron: Biol Blood Marrow Transplant 2005;11(2 Suppl 1):66-7.
DOI: 10.1016/j.bbmt.2004.12.199
http://www.bbmt.org/article/S1083-8791(04)00851-1/fulltext (opent nieuw venster)
Safety and survival outcomes for bloodless transplantation in patients with myeloma. (opent nieuw venster)
Bron: Cancer 2019;125(2):185-93.
Geïndexeerd: PubMed 30480777
DOI: 10.1002/cncr.31677
https://www.ncbi.nlm.nih.gov/pubmed/30480777 (opent nieuw venster)
Bloodless tandem autologous transplant in Jehovah's Witness patients. (opent nieuw venster)
Bron: Bone Marrow Transplant 2018. [Epub ahead of print]
Geïndexeerd: PubMed 29795417
DOI: 10.1038/s41409-018-0132-6
https://www.ncbi.nlm.nih.gov/pubmed/29795417 (opent nieuw venster)
Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (opent nieuw venster)
Bron: Bone Marrow Transplant 2003;32(4):433-6.
Geïndexeerd: PubMed 12900781
DOI: 10.1038/sj.bmt.1704179
https://www.ncbi.nlm.nih.gov/pubmed/12900781 (opent nieuw venster)
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (opent nieuw venster)
Bron: Bone Marrow Transplant 2005;36(8):715-20.
Geïndexeerd: PubMed 16113672
DOI: 10.1038/sj.bmt.1705126
https://www.ncbi.nlm.nih.gov/pubmed/16113672 (opent nieuw venster)
SCT in Jehovah's Witnesses: the bloodless transplant. (opent nieuw venster)
Bron: Bone Marrow Transplant 2008;41(10):837-44.
Geïndexeerd: PubMed 18246110
DOI: 10.1038/bmt.2008.5
https://www.ncbi.nlm.nih.gov/pubmed/18246110 (opent nieuw venster)